지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.1
- 수록면
- 314 - 324 (11page)
- DOI
- 10.4143/crt.2022.015
이용수
초록· 키워드
오류제보하기
Purpose Prognostic Index for Natural Killer Lymphoma (PINK) is the most widely accepted prognostic model for patients withextranodal natural killer/T-cell lymphoma (ENKTL) treated with non-anthracycline–based therapy. We aimed to evaluate the prognostic implications of serum β-2 microglobulin (β2M) in the context of PINK and proposed a new prognostic model.Materials and Methods A total of 138 patients who were newly diagnosed with ENKTL and treated with non-anthracycline-based chemotherapy were identified. The cut-off value of high serum β2M was calculated by maximal-chi square methods (4.1 mg/L). A new prognostic model incorporating serum β2M into PINK was proposed and validated in an independent validation cohort (n=88).Results The patients’ median age was 53.5 years (range, 19 to 80 years). Patients with high serum β2M levels had significantly worse overall survival (OS) and progression-free survival (PFS). In multivariate analysis, high serum β2M was an independent adverse prognostic factor for OS. A new PINK-B (Prognostic Index for Natural Killer Lymphoma-serum β-2 microglobulin) model stratifiedpatients into three groups with distinct OS and PFS in the training cohort (3-year OS, 84.1% [95% confidence interval, 75.1 to 94.2], 46.8% [36.1 to 60.8] and 17.6% [6.3 to 49.2] for the low-, intermediate, and high-risk groups, respectively; 3-year PFS, 70.6% [59.4 to 83.8], 35.9% [25.9 to 49.8], and 7.35% [1.1 to 46.7] for the low-, intermediate-, and high-risk groups, respectively). The PINK-B model was further validated in an independent cohort.Conclusion Serum β2M is an independent prognostic factor for ENKTL patients. The new serum β2M-based prognostic model may be useful for identifying ultra-high-risk patients, and it can easily be adopted into daily clinical practice.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy
Cancer Research and Treatment
2019 .01
-
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels
Cancer Research and Treatment
2021 .01
-
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
Journal of Gastric Cancer
2017 .06
-
The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
Yonsei Medical Journal
2016 .01
-
Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors
Investigative and Clinical Urology
2021 .01
-
An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer
Cancer Research and Treatment
2021 .01
-
Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Prognostic Implication of Inflammation-Based Prognostic Scores in Patients with Pancreatic Cancer Treated with Pancreatic Surgery
대한외과학회 학술대회 초록집
2018 .11
-
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
Yonsei Medical Journal
2016 .01
-
Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer
Journal of Breast Cancer
2018 .01
-
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
Blood Research
2017 .01
-
A Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type with Dermatomyositis
Annals of Dermatology
2021 .01
-
Is there any Potential Clinical Impact of Serum Phosphorus and Magnesium in Patients with Lung Cancer at First Diagnosis? A Multi-institutional Study
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Is Body Mass Index a Useful Prognostic Factor for Critically Ill Patients?
Acute and Critical Care
2015 .01
-
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
Cancer Research and Treatment
2016 .01
-
Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer
대한외과학회 학술대회 초록집
2021 .05
-
Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma
Blood Research
2020 .01
-
Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma
Blood Research
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0